TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
- PMID: 29092952
- PMCID: PMC6042652
- DOI: 10.1158/0008-5472.CAN-17-0307
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Abstract
Recent clinical successes of cancer immunotherapy necessitate the investigation of the interaction between malignant cells and the host immune system. However, elucidation of complex tumor-immune interactions presents major computational and experimental challenges. Here, we present Tumor Immune Estimation Resource (TIMER; cistrome.shinyapps.io/timer) to comprehensively investigate molecular characterization of tumor-immune interactions. Levels of six tumor-infiltrating immune subsets are precalculated for 10,897 tumors from 32 cancer types. TIMER provides 6 major analytic modules that allow users to interactively explore the associations between immune infiltrates and a wide spectrum of factors, including gene expression, clinical outcomes, somatic mutations, and somatic copy number alterations. TIMER provides a user-friendly web interface for dynamic analysis and visualization of these associations, which will be of broad utilities to cancer researchers. Cancer Res; 77(21); e108-10. ©2017 AACR.
©2017 American Association for Cancer Research.
Conflict of interest statement
The authors declare no potential conflicts of interest.
Figures
Similar articles
-
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.Genome Biol. 2016 Aug 22;17(1):174. doi: 10.1186/s13059-016-1028-7. Genome Biol. 2016. PMID: 27549193 Free PMC article.
-
TIMER2.0 for analysis of tumor-infiltrating immune cells.Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407. Nucleic Acids Res. 2020. PMID: 32442275 Free PMC article.
-
TIP: A Web Server for Resolving Tumor Immunophenotype Profiling.Cancer Res. 2018 Dec 1;78(23):6575-6580. doi: 10.1158/0008-5472.CAN-18-0689. Epub 2018 Aug 28. Cancer Res. 2018. PMID: 30154154
-
Computational approaches for characterizing the tumor immune microenvironment.Immunology. 2019 Oct;158(2):70-84. doi: 10.1111/imm.13101. Immunology. 2019. PMID: 31347163 Free PMC article. Review.
-
In-vivo imaging of tumor-infiltrating immune cells: implications for cancer immunotherapy.Q J Nucl Med Mol Imaging. 2018 Mar;62(1):56-77. doi: 10.23736/S1824-4785.17.03052-7. Epub 2017 Nov 30. Q J Nucl Med Mol Imaging. 2018. PMID: 29191000 Review.
Cited by
-
Identification of biomarkers, pathways and potential therapeutic target for docetaxel resistant prostate cancer.Bioengineered. 2021 Dec;12(1):2377-2388. doi: 10.1080/21655979.2021.1936831. Bioengineered. 2021. PMID: 34077304 Free PMC article.
-
Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors.Front Immunol. 2022 Oct 13;13:1008778. doi: 10.3389/fimmu.2022.1008778. eCollection 2022. Front Immunol. 2022. PMID: 36311703 Free PMC article.
-
Comprehensive analyses identify RIPOR2 as a genomic instability-associated immune prognostic biomarker in cervical cancer.Front Immunol. 2022 Aug 26;13:930488. doi: 10.3389/fimmu.2022.930488. eCollection 2022. Front Immunol. 2022. PMID: 36091054 Free PMC article.
-
Identification and validation of the prognostic value of immune-related genes in non-small cell lung cancer.Am J Transl Res. 2020 Sep 15;12(9):5844-5865. eCollection 2020. Am J Transl Res. 2020. PMID: 33042464 Free PMC article.
-
GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma.Front Oncol. 2022 Aug 26;12:968610. doi: 10.3389/fonc.2022.968610. eCollection 2022. Front Oncol. 2022. PMID: 36091126 Free PMC article.
References
-
- Hackl H, Charoentong P, Finotello F, Trajanoski Z. Computational genomics tools for dissecting tumour-immune cell interactions. Nature reviews Genetics. 2016;17:441–58. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
